Optimer Pharmaceuticals, Inc. (OPTR): Q4 EPS of $0.02 may not be comparable to consensus of by...

|About: Optimer Pharmaceuticals,... (OPTR)|By:, SA News Editor
Optimer Pharmaceuticals, Inc. (OPTR): Q4 EPS of $0.02 may not be comparable to consensus of by -$0.38. Gross product sales of $21.3M. Shares +11.5% premarket. (PR)